EP3911360A4 - METHODS OF MODULATING CORTICOSTEROID RESPONSE - Google Patents

METHODS OF MODULATING CORTICOSTEROID RESPONSE Download PDF

Info

Publication number
EP3911360A4
EP3911360A4 EP20741802.1A EP20741802A EP3911360A4 EP 3911360 A4 EP3911360 A4 EP 3911360A4 EP 20741802 A EP20741802 A EP 20741802A EP 3911360 A4 EP3911360 A4 EP 3911360A4
Authority
EP
European Patent Office
Prior art keywords
methods
modulating
corticosteroid response
response
modulating corticosteroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20741802.1A
Other languages
German (de)
French (fr)
Other versions
EP3911360A1 (en
Inventor
Ben ZWEIFEL
Prabha Sharma
Rick FITCH
Karen GALEN
Dale Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Ard Ip Unlimited Co
Original Assignee
Mallinckrodt Ard Ip Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Ard Ip Unlimited Co filed Critical Mallinckrodt Ard Ip Unlimited Co
Publication of EP3911360A1 publication Critical patent/EP3911360A1/en
Publication of EP3911360A4 publication Critical patent/EP3911360A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP20741802.1A 2019-01-18 2020-01-21 METHODS OF MODULATING CORTICOSTEROID RESPONSE Pending EP3911360A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962794369P 2019-01-18 2019-01-18
PCT/US2020/014444 WO2020150738A1 (en) 2019-01-18 2020-01-21 Methods of modulating corticosteroid response

Publications (2)

Publication Number Publication Date
EP3911360A1 EP3911360A1 (en) 2021-11-24
EP3911360A4 true EP3911360A4 (en) 2022-09-21

Family

ID=71613659

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20741802.1A Pending EP3911360A4 (en) 2019-01-18 2020-01-21 METHODS OF MODULATING CORTICOSTEROID RESPONSE

Country Status (3)

Country Link
EP (1) EP3911360A4 (en)
CA (1) CA3125351A1 (en)
WO (1) WO2020150738A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3973978A1 (en) * 2020-09-25 2022-03-30 Mallinckrodt Ard IP Unlimited Company Methods of modulating corticosteroid response
WO2023034819A1 (en) * 2021-08-30 2023-03-09 Mallinckrodt Ard Ip Unlimited Company Pre-filled manual injector apparatus
US11975047B1 (en) 2022-10-28 2024-05-07 Ani Pharmaceuticals, Inc. Methods for storing and warming purified corticotropin compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796416B1 (en) * 2010-10-25 2014-08-05 Questcor Pharmaceuticals, Inc ACTH prophylactic treatment of renal disorders
US10232018B2 (en) * 2013-03-14 2019-03-19 Mallinckrodt Ard Ip Limited ACTH for treatment of acute respiratory distress syndrome

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BENKO A L ET AL: "Repository corticotrophin injection exerts direct acute effects on human B cell gene expression distinct from the actions of glucocorticoids", CLINICAL AND EXPERIMENTAL IMMUNOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 192, no. 1, 12 January 2018 (2018-01-12), pages 68 - 81, XP071086162, ISSN: 0009-9104, DOI: 10.1111/CEI.13089 *
DUARTE-GARC�A ALI ET AL: "Older Drugs With Limited Trial Evidence: Are They Worth the Expense? The Case of Repository Corticotropin Marketed as H.P. Acthar Gel.", ANNALS OF INTERNAL MEDICINE 04 06 2019, vol. 170, no. 11, 4 June 2019 (2019-06-04), pages 791 - 792, XP009538173, ISSN: 1539-3704 *
See also references of WO2020150738A1 *
WRIGHT D ET AL: "Reduced steroidogenic activity of Repository Corticotropin Injection (RCI) induces a distinct cytokine response following T cell activation in vivo", ANNALS OF THE RHEUMATIC DISEASES 20190601 BMJ PUBLISHING GROUP NLD, vol. 78, no. Supplement 2, 1 June 2019 (2019-06-01), XP009538172, ISSN: 1468-2060 *

Also Published As

Publication number Publication date
CA3125351A1 (en) 2020-07-23
WO2020150738A1 (en) 2020-07-23
EP3911360A1 (en) 2021-11-24

Similar Documents

Publication Publication Date Title
EP3876747A4 (en) METHODS OF MODULATING GASTROINTESTINAL METABOLITES
IL271149A (en) Compounds for modulating s1p1 activity and methods of using them
EP4055969C0 (en) CONFIGURED PROCEDURE FOR SHARING CHANNEL TIMES
EP3484524A4 (en) COMPOUNDS AND METHODS FOR MODULATING SMN2
EP3576737A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE ACTIVITY OF SHORT CHAIN DEHYDROGENASE
EP3585171A4 (en) COMPOSITIONS AND RELATED PROCEDURES FOR MODULATING ENDOSYMBIONS
IL290298A (en) Chimeric compounds that modulate t cells and methods of using them
IL286681A (en) Compounds and methods for modulating ube3a-ats
EP3307782A4 (en) Methods and antibodies for modulation of immunoresponse
EP3436006C0 (en) Methods and compositions for modulating frataxin expression
EP3876749A4 (en) METHODS FOR SELECTIVE GASTROINTESTINAL MICROBIAL GROWTH MODULATION
EP3911360A4 (en) METHODS OF MODULATING CORTICOSTEROID RESPONSE
EP3914714A4 (en) SYSTEMS AND METHODS FOR MODULATING CRISPR ACTIVITY
EP3860618A4 (en) METHODS AND COMPOSITIONS FOR MODULATING TAU PROTEINS
EP3541848A4 (en) METHODS OF LIGATING PROTEINS AND USES THEREOF
EP3676983A4 (en) METHOD AND EQUIPMENT FOR TRANSMISSION OF UPLINK CONTROL INFORMATION AND SETTING THE UPLINK DELAY
EP4010004A4 (en) COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
EP3484310A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING SWEET FLAVOR
EP3870206A4 (en) COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION
EP3934674A4 (en) MODULATION OF NEURO-INFLAMMATION
EP4069280A4 (en) METHOD FOR INDUCING INTERMITTENT FASTING AND MODULATING AUTOPHAGY
EP3485016A4 (en) COMPOUNDS AND METHODS FOR MODULATING TRANSCRIPTION PROCESSING
EP3801537A4 (en) COMPOUNDS AND METHODS FOR MODULATING G PROTEIN COUPLED RECEPTORS
EP3605921A4 (en) METHOD AND DEVICE FOR TRANSMISSION OF THE PILOT FREQUENCY OF CHANNEL STATUS INFORMATION, PROCESSOR AND STORAGE MEDIUM
EP3870269A4 (en) DEVICES, SYSTEMS AND KITS FOR ELECTROPORATION AND METHODS OF USE THEREOF

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210804

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40057688

Country of ref document: HK

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220822

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/94 20060101ALI20220816BHEP

Ipc: C07K 7/06 20060101ALI20220816BHEP

Ipc: A61K 9/06 20060101ALI20220816BHEP

Ipc: A61K 45/06 20060101ALI20220816BHEP

Ipc: A61K 38/16 20060101ALI20220816BHEP

Ipc: A61K 38/35 20060101AFI20220816BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230727